## **Core Concept**
Pulmonary fibrosis is a condition characterized by scarring of lung tissue, leading to respiratory dysfunction. It can be caused by various factors, including medications. Certain drugs are known to have pulmonary fibrosis as a potential side effect.

## **Why the Correct Answer is Right**
Bleomycin is a chemotherapeutic agent used in the treatment of various cancers, including testicular cancer, ovarian cancer, and Hodgkin's lymphoma. One of the well-known side effects of bleomycin is pulmonary toxicity, which can manifest as pneumonitis and can progress to pulmonary fibrosis. The mechanism involves the generation of reactive oxygen species that damage lung tissue. The risk of pulmonary fibrosis is dose-dependent and can be fatal.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain antineoplastic agents can cause lung injury, the specific association with pulmonary fibrosis as a most common complication is not as strong as with bleomycin.
- **Option B:** This option does not provide a specific drug, making it impossible to assess its relevance to pulmonary fibrosis directly.
- **Option C:** Similarly, without a specific drug listed, it's challenging to evaluate its association with pulmonary fibrosis.
- **Option D:** This option also lacks specificity but mentioning "none of the above" implies that none of the listed drugs are commonly associated with pulmonary fibrosis, which is incorrect given the known effects of bleomycin.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that bleomycin-induced pulmonary fibrosis is dose-dependent, and monitoring lung function tests is crucial during its use. A classic clinical correlation is that patients who receive bleomycin are at risk of developing pulmonary fibrosis, especially if they receive high cumulative doses.

## **Correct Answer:** . Bleomycin